Literature DB >> 27512962

Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis.

Rahul Mittal1, Luca H Debs1, Amit P Patel1, Desiree Nguyen1, Kunal Patel1, Gregory O'Connor2, M'hamed Grati1, Jeenu Mittal1, Denise Yan1, Adrien A Eshraghi1, Sapna K Deo2, Sylvia Daunert2, Xue Zhong Liu1.   

Abstract

Neurotransmitters, including catecholamines and serotonin, play a crucial role in maintaining homeostasis in the human body. Studies on these neurotransmitters mainly revolved around their role in the "fight or flight" response, transmitting signals across a chemical synapse and modulating blood flow throughout the body. However, recent research has demonstrated that neurotransmitters can play a significant role in the gastrointestinal (GI) physiology. Norepinephrine (NE), epinephrine (E), dopamine (DA), and serotonin have recently been a topic of interest because of their roles in the gut physiology and their potential roles in GI and central nervous system pathophysiology. These neurotransmitters are able to regulate and control not only blood flow, but also affect gut motility, nutrient absorption, GI innate immune system, and the microbiome. Furthermore, in pathological states, such as inflammatory bowel disease (IBD) and Parkinson's disease, the levels of these neurotransmitters are dysregulated, therefore causing a variety of GI symptoms. Research in this field has shown that exogenous manipulation of catecholamine serum concentrations can help in decreasing symptomology and/or disease progression. In this review article, we discuss the current state-of-the-art research and literature regarding the role of neurotransmitters in regulation of normal GI physiology, their impact on several disease processes, and novel work focused on the use of exogenous hormones and/or psychotropic medications to improve disease symptomology. J. Cell. Physiol. 232: 2359-2372, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27512962      PMCID: PMC5772764          DOI: 10.1002/jcp.25518

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  169 in total

Review 1.  Peripheral mechanisms in irritable bowel syndrome.

Authors:  Michael Camilleri
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

2.  Regulation of fat intake in the absence of flavour signalling.

Authors:  Jozélia G Ferreira; Luis A Tellez; Xueying Ren; Catherine W Yeckel; Ivan E de Araujo
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

3.  Buspirone, a new drug for the management of patients with ineffective esophageal motility?

Authors:  Charlotte Scheerens; Jan Tack; Nathalie Rommel
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

4.  Dopamine-dependent inhibition of jejunal Na+-K+-ATPase during high-salt diet in young but not in adult rats.

Authors:  M A Vieira-Coelho; V A Teixeira; Y Finkel; P Soares-Da-Silva; A M Bertorello
Journal:  Am J Physiol       Date:  1998-12

5.  The effect of the human gut-signalling hormone, norepinephrine, on the growth of the gastric pathogen Helicobacter pylori.

Authors:  Neil C Doherty; Amanda Tobias; Sue Watson; John C Atherton
Journal:  Helicobacter       Date:  2009-06       Impact factor: 5.753

6.  Effects of a dietary excess of leucine on the metabolism of tryptophan in the rat: a mechanism for the pellagragenic action of leucine.

Authors:  D A Bender
Journal:  Br J Nutr       Date:  1983-07       Impact factor: 3.718

7.  Food reward in the absence of taste receptor signaling.

Authors:  Ivan E de Araujo; Albino J Oliveira-Maia; Tatyana D Sotnikova; Raul R Gainetdinov; Marc G Caron; Miguel A L Nicolelis; Sidney A Simon
Journal:  Neuron       Date:  2008-03-27       Impact factor: 17.173

8.  Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.

Authors:  Julia Farache; Idan Koren; Idan Milo; Irina Gurevich; Ki-Wook Kim; Ehud Zigmond; Glaucia C Furtado; Sergio A Lira; Guy Shakhar
Journal:  Immunity       Date:  2013-02-07       Impact factor: 31.745

9.  Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.

Authors:  Feng-Yan Yu; Shao-Gang Huang; Hai-Yan Zhang; Hua Ye; Hong-Gang Chi; Ying Zou; Ru-Xi Lv; Xue-Bao Zheng
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

10.  Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice.

Authors:  Zhi Shan Li; Claudia Schmauss; Abigail Cuenca; Elyanne Ratcliffe; Michael D Gershon
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

View more
  99 in total

Review 1.  Factors inhibiting intestinal calcium absorption: hormones and luminal factors that prevent excessive calcium uptake.

Authors:  Kannikar Wongdee; Mayuree Rodrat; Jarinthorn Teerapornpuntakit; Nateetip Krishnamra; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2019-06-20       Impact factor: 2.781

Review 2.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

Review 3.  The microbiota-gut-brain axis: An emerging role for the epigenome.

Authors:  Tijs Louwies; Anthony C Johnson; Albert Orock; Tian Yuan; Beverley Greenwood-Van Meerveld
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-05

Review 4.  Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota.

Authors:  David J Durgan
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

Review 5.  Succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism: an update on pharmacological and enzyme-replacement therapeutic strategies.

Authors:  Kara R Vogel; Garrett R Ainslie; Dana C Walters; Alice McConnell; Sameer C Dhamne; Alexander Rotenberg; Jean-Baptiste Roullet; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2018-02-19       Impact factor: 4.982

6.  Differential serotonergic modulation across the main and accessory olfactory bulbs.

Authors:  Zhenbo Huang; Nicolas Thiebaud; Debra Ann Fadool
Journal:  J Physiol       Date:  2017-03-31       Impact factor: 5.182

Review 7.  Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension.

Authors:  Jasenka Zubcevic; Elaine M Richards; Tao Yang; Seungbum Kim; Colin Sumners; Carl J Pepine; Mohan K Raizada
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

Review 8.  Brain-Gut Axis: Clinical Implications.

Authors:  Julie Khlevner; Yeji Park; Kara Gross Margolis
Journal:  Gastroenterol Clin North Am       Date:  2018-09-28       Impact factor: 3.806

Review 9.  The gut microbiome and neuropsychiatric disorders: implications for attention deficit hyperactivity disorder (ADHD).

Authors:  Kalai Mathee; Trevor Cickovski; Alok Deoraj; Melanie Stollstorff; Giri Narasimhan
Journal:  J Med Microbiol       Date:  2020-01       Impact factor: 2.472

10.  Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson's disease treatment.

Authors:  Luminita Crisan; Daniela Istrate; Alina Bora; Liliana Pacureanu
Journal:  Mol Divers       Date:  2020-11-25       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.